Metabolic

Research Peptides for Metabolic Pathway Study
This category holds compounds that sit at the center of metabolic research. Retatrutide is a triple-agonist studied at the GLP-1, GIP, and glucagon receptors, the most actively researched class of metabolic compounds in the literature since 2022. Cagrilintide is studied as an amylin-receptor agonist, a separate pathway in the same broad field of energy-balance and glucose-regulation research.
Etched does not carry Semaglutide or Tirzepatide. The focus here is on the next-generation and single-mechanism research tools rather than the older incretin SKUs. As with every category, these are research areas. The literature examines receptor pharmacology and metabolic signaling in models, not results in people.
For background on incretin and amylin receptor biology, read the Retatrutide and Cagrilintide research summaries in our Research Library at etchedresearch.com/research. Each lot ships with a batch-specific Certificate of Analysis from Janoshik Analytical, purity verified at greater than or equal to 99% by HPLC.
For research use only. Not for human consumption.